In a recent ConsumerLab.com (White Plains, NY) review of omega-3 supplements, 7 out of 24 products were found to have quality problems.
In a recent ConsumerLab.com (White Plains, NY) review of omega-3 supplements, 7 out of 24 products were found to have quality problems.
ConsumerLab’s research team performed the quality tests on store-bought fish oil, krill oil, and algal oil supplements containing eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA).
Claimed content proved to be a concern with some products provided less than 20% of the claimed EPA/DHA content to 80% over the claimed amount.
Other issues included a children’s fish oil that was found spoiled at the time of purchase, an enteric-coated fish oil that released its nutrients too early, and a pet supplement bearing PCB levels beyond the contamination limit. Several product labels even ran quality claims with no regulatory basis.
Withstanding the poor results of several omega-3 supplements, 17 products did pass testing. ConsumerLab also reports that 15 other omega-3 products passed the organization’s voluntary certification program.
To find out more details about each supplement reviewed, visit ConsumerLab.com.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.